AI Eye Podcast 519: GBT Evaluating Adaptation of qTerm for Hotel Industry, IBM (NYSE: $IBM) Partners with Palantir (NYSE: $PLTR) on AI-Infused Solution for Business Applications
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
GBT Tokenize Engaged M Squared Associates to Support FDA 510(k) Submission for qTerm
GBT Technologies Inc.January 28, 2021 GMT
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”) announced today that GBT Tokenize Corp (“GBT/Tokenize”) engaged M Squared Associates (M2) to assist with developing the FDA premarket strategy for its qTerm device. For more than 20 years, M2 has been providing a full range of regulatory, quality and clinical consulting services to US and international medical technology firms. M2 specializes in devices, biologics and combination products that are reviewed by FDA’s Center for Devices and Radiological Health (CDRH).
AI Eye Podcast 513: GBT Begins qTerm Improvements in Preparation for FDA Certification, BlackBerry (NYSE: $BB) is Expanding Its Strategic Partnership with Baidu (NasdaqGS: $BIDU) to Power Next-Gen Autonomous Driving Tech
Point Roberts, WA and Vancouver, BC - January 26, 2021 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today s edition of
The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence - featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).
Listen to today s podcast:
SHARE PODCAST:
Stocks discussed: (OTCPINK:GTCH) (NYSE:BB) (NasdaqGS:BIDU)
GBT Technologies Inc. (OTC PINK:GTCH, through its joint venture GBT Tokenize Corp, has begun a series of improvements for its qTerm human vital signs device as preparations for its FDA certification process. According to the press release, these improvements aim to achieve hig